$3.5 Bn Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035 Cell Therapy, Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions

The cell and gene therapy CRO market presents growth opportunities driven by FDA-approved therapies, over 90 global approvals, and 3,500 trials across 16 therapeutic areas, primarily in North America. Key segments include CAR-T therapy, oncological disorders, and industry players. Asia-Pacific shows promising growth.

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy CRO Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions" has been added to ResearchAndMarkets.com's offering.

The global cell and gene therapy CRO market is poised for substantial growth, escalating from USD 1.7 billion in 2025 to USD 3.5 billion by 2035, at a CAGR of 7.1% during this period.

The sector's expansion is driven by breakthroughs in cell and gene therapies and the increasing number of FDA-approved treatments addressing various diseases, particularly rare and complex ones. Currently, over 90 such therapies have been approved globally, with notable examples including Elvediys, Fucaso, and Vyjuvek.

Furthermore, over 3,500 clinical trials are actively exploring these therapies across 16 therapeutic areas. Contract Research Organizations (CROs) play a pivotal role by providing expertise in optimizing study designs, navigating regulatory frameworks, and ensuring smooth transitions from preclinical to clinical phases. Over 105 industry players claim capabilities in offering diverse contract research services.

Market Segmentation Highlights

The CRO market is segmented by therapy type, genetic modification, development stage, therapeutic area, end users, and geographic regions. The CAR-T segment dominates cell therapy, owing to its effectiveness against haematological malignancies. The ex vivo genetic modification holds a significant market share due to its utilization of viral vectors for gene integration. Clinical trials continue to capture the largest market share due to stringent regulatory compliance. Oncological disorders remain the largest therapeutic focus, and industry players continue to lead the market.

Key Insights from the Cell and Gene Therapy CRO Market Report

• More than 105 companies, including both startups and established firms, offer contract research services, predominantly from North America.
• About 20% provide a full spectrum of clinical services, indicating a trend towards comprehensive service offerings.
• Acquisitions are the most common partnership model, with 58% of such initiatives aimed at expanding service capabilities.
• Since 2019, over 3,000 cell therapy clinical trials have been registered, with over 70% actively recruiting patients.
• Around 500 gene therapy trials, enrolling over 48,000 patients, are underway globally.
• Demand for cell and gene therapies is prompting stakeholders to enhance their service size and capabilities.
• Approximately 25% of market revenue is expected to stem from oncological treatments.
• China's CRO market is expected to grow faster, reflecting a global shift in market dynamics.

Notable Players Profiled in the Report

• Altasciences
• Allucent
• CMIC
• Labcorp
• Linical
• Medpace
• PPD
• Precision for Medicine
• QPS
• Syneos Health
• CMED
• ICON
• Pharmalex
• Novotech

Key Topics Covered:

1. Preface

2. Research Methodology

3. Economic And Other Project Specific Considerations

4. Executive Summary

5. Introduction

6. Guide To Outsourcing

7. Market Landscape

8. Company Profiles

9. Benchmarking Analysis

10. Partnerships And Collaborations

11. Mergers And Acquisitions

12. Key Acquisition Targets

13. Clinical Trial Analysis

14. Total Cost Of Ownership

15. Swot Analysis

16. Global Cell And Gene Therapy Cro Market

17. Cell And Gene Therapy Cro Market, By Type Of Cell Therapy

18. Cell And Gene Therapy Cro Market, By Type Of Genetic Modification

19. Cell And Gene Therapy Cro Market, By Stage Of Development

20. Cell And Gene Therapy Cro Market, By Therapeutic Area

21. Cell And Gene Therapy Cro Market, By End-Users

22. Cell And Gene Therapy Cro Market, By Key Geographical Regions

23. Executive Insights

24. Concluding Remarks

25. Appendix I: Tabulated Data

26. Appendix II: List Of Companies And Organizations

• Altasciences
• Allucent
• CMIC
• Labcorp
• Linical
• Medpace
• PPD
• Precision for Medicine
• QPS
• Syneos Health
• CMED
• ICON
• Pharmalex
• Novotech

For more information about this report visit https://www.researchandmarkets.com/r/dnoghw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900